Table 1.

Homing of Ex Vivo–Expanded Progenitor Cells In Vivo

Experiment No. No. Transplanted (mean ± SEM) No. Recovered per Organ
PKH26+ CellsPKH26+ CFCs (mean ± SEM)
PKH26+ Cells PKH26+ CFCs Marrow% Input Spleen % Input Marrow % Input Spleen% Input
1  1.2 × 107 356,000 ± 92,000  91,800  0.77  37,400  0.31 190 ± 100  0.054  120 ± 90  0.032  
8.8 × 106 433,130 ± 35,000  27,500 0.31  58,800  0.67  2,870 ± 650  0.66 6,730 ± 270  1.55  
3  9.7 × 106 503,360 ± 43,560  50,400  0.52  169,520  1.75 4,870 ± 220  0.97  17,220 ± 140  3.42  
Pooled    0.53 ± 0.13  0.91 ± 0.43   0.56 ± 0.27  1.67 ± 0.98 
Experiment No. No. Transplanted (mean ± SEM) No. Recovered per Organ
PKH26+ CellsPKH26+ CFCs (mean ± SEM)
PKH26+ Cells PKH26+ CFCs Marrow% Input Spleen % Input Marrow % Input Spleen% Input
1  1.2 × 107 356,000 ± 92,000  91,800  0.77  37,400  0.31 190 ± 100  0.054  120 ± 90  0.032  
8.8 × 106 433,130 ± 35,000  27,500 0.31  58,800  0.67  2,870 ± 650  0.66 6,730 ± 270  1.55  
3  9.7 × 106 503,360 ± 43,560  50,400  0.52  169,520  1.75 4,870 ± 220  0.97  17,220 ± 140  3.42  
Pooled    0.53 ± 0.13  0.91 ± 0.43   0.56 ± 0.27  1.67 ± 0.98 

Unfractionated (experiment 1) or Sca-1+c-kit+Lin(experiments 2 and 3) BM cells were cultured for 9 days in serum-free medium supplemented with IL-3, IL-6, G-CSF, and SCF, or IL-6, IL-11, G-CSF, SCF, FLK, and TPO, respectively. Expanded cells were stained with PKH26, assayed for CFCs, and then injected IV into lethally irradiated syngeneic mice. Three hours later, marrow and spleen cells were procured and counted to determine total-organ cellularity. PKH26+ cells were quantitated by FACS and then sorted and assayed for CFCs. The percent recovery of input cells and CFCs in each organ was calculated as described in the legend to Fig 2.

Close Modal

or Create an Account

Close Modal
Close Modal